Sevion Therapeutics

Sevion is a biopharmaceutical company developing and acquiring innovative candidate products for the treatment of cancer and immune diseases. The company is advancing a pipeline of proprietary and collaborative product candidates utilizing its unique antibody technology platform. The company's antibody pipeline is developing technologies that enable the discovery of innovative biotherapies, as well as previously difficult-to-target proteins such as multi-transmembrane proteins and ion channels, which play important roles in various diseases. The company has also developed the first protein nanocage system, which allows for the delivery of nucleic acids and other payloads to target cells.